Epidemiology and Economic Outcomes Associated with Timely versus Delayed Receipt of Appropriate Antibiotic Therapy among US Patients Hospitalized for Native Septic Arthritis: A Retrospective Cohort Study
- PMID: 36551387
- PMCID: PMC9774525
- DOI: 10.3390/antibiotics11121732
Epidemiology and Economic Outcomes Associated with Timely versus Delayed Receipt of Appropriate Antibiotic Therapy among US Patients Hospitalized for Native Septic Arthritis: A Retrospective Cohort Study
Abstract
Timely administration of appropriate antibiotic therapy is associated with better patient outcomes and lower costs of care compared to delayed appropriate therapy, yet initial treatment is often empiric since causal pathogens are typically unknown upon presentation. The challenge for clinicians is balancing selection of adequate coverage treatment regimens, adherence to antimicrobial stewardship principles to deter resistance, and financial constraints. This retrospective cohort study aimed to assess the magnitude and impact of delayed appropriate antibiotic therapy among patients hospitalized with septic arthritis (SA) in the U.S. from 2017 to 2019 using healthcare encounter data. Timely appropriate therapy was defined as the receipt of antibiotic(s) with in vitro activity against identified pathogens within two days of admission; all other patients were assumed to have received delayed appropriate therapy. Of the 517 patients admitted to hospital for SA who met all selection criteria, 26 (5.0%) received delayed appropriate therapy. In inverse-probability-treatment-weighting-adjusted analyses, the receipt of delayed appropriate therapy was associated with an additional 1.1 days of antibiotic therapy, 1.4 days in length of stay, and $3531 in hospital costs (all vs. timely appropriate therapy; all p ≤ 0.02). Timely appropriate therapy was associated with a twofold increased likelihood of antibiotic de-escalation during the SA admission.
Keywords: antibiotic; arthritis; cost measures; delayed; health care utilization.
Conflict of interest statement
Tristan T. Timbrook and Rachael B. Hemmert are employed by the research sponsor, BioMérieux, Inc. Dr. Joan-Miquel Balada-Llasat is a consultant for BioMérieux, Inc. Nicole Stamas, Tom Vincent, Cynthia Saiontz-Martinez, and Ariel Berger are employed by Evidera, a health economics outcomes research (HEOR) consultancy with previous and ongoing engagements with BioMérieux and other pharmaceutical, biotech, and medical device companies.
Figures

Similar articles
-
Antimicrobial Resistance or Delayed Appropriate Therapy-Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?Open Forum Infect Dis. 2019 Apr 23;6(6):ofz194. doi: 10.1093/ofid/ofz194. eCollection 2019 Jun. Open Forum Infect Dis. 2019. PMID: 31198817 Free PMC article.
-
Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections.Am J Med Sci. 2019 Feb;357(2):103-110. doi: 10.1016/j.amjms.2018.11.009. Epub 2018 Nov 22. Am J Med Sci. 2019. PMID: 30665490
-
Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus.Clin Ther. 2018 Mar;40(3):406-414.e2. doi: 10.1016/j.clinthera.2018.01.010. Epub 2018 Feb 15. Clin Ther. 2018. PMID: 29454592
-
Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.J Hosp Med. 2012;7 Suppl 1:S13-21. doi: 10.1002/jhm.983. J Hosp Med. 2012. PMID: 23737333 Review.
-
Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.J Hosp Med. 2012;7 Suppl 1:S13-21. doi: 10.1002/jhm.983. J Hosp Med. 2012. PMID: 23677630 Review.
Cited by
-
Septic arthritis score (SAS) - a novel clinical prediction model for the probability of septic arthritis in the adult native knee.BMC Infect Dis. 2025 Jul 18;25(1):926. doi: 10.1186/s12879-025-11306-6. BMC Infect Dis. 2025. PMID: 40681984 Free PMC article.
-
Potential value of a rapid syndromic multiplex PCR for the diagnosis of native and prosthetic joint infections: a real-world evidence study.J Bone Jt Infect. 2024 Feb 28;9(1):87-97. doi: 10.5194/jbji-9-87-2024. eCollection 2024. J Bone Jt Infect. 2024. PMID: 38601005 Free PMC article.
-
Arthroscopy or arthrotomy for native knee septic arthritis: A systematic review.J Exp Orthop. 2024 Jun 6;11(3):e12041. doi: 10.1002/jeo2.12041. eCollection 2024 Jul. J Exp Orthop. 2024. PMID: 38846377 Free PMC article.
-
Prospective evaluation of real-world performance and clinical impact of the Biofire FilmArray joint infection panel.Microbiol Spectr. 2025 Apr;13(4):e0223924. doi: 10.1128/spectrum.02239-24. Epub 2025 Feb 25. Microbiol Spectr. 2025. PMID: 39998242 Free PMC article.
-
Multicenter evaluation of the BIOFIRE Joint Infection Panel for the detection of bacteria, yeast, and AMR genes in synovial fluid samples.J Clin Microbiol. 2023 Nov 21;61(11):e0035723. doi: 10.1128/jcm.00357-23. Epub 2023 Oct 25. J Clin Microbiol. 2023. PMID: 37877730 Free PMC article.
References
-
- Ferrand J., El Samad Y., Brunschweiler B., Grados F., Dehamchia-Rehailia N., Séjourne A., Schmit J.-L., Gabrion A., Fardellone P., Paccou J. Morbimortality in adult patients with septic arthritis: A three-year hospital-based study. BMC Infect. Dis. 2016;16:239. doi: 10.1186/s12879-016-1540-0. - DOI - PMC - PubMed
-
- Lodise T.P., Berger A., Altincatal A., Wang R., Bhagnani T., Gillard P., Bonine N.G. Antimicrobial Resistance or Delayed Appropriate Therapy-Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae? Open Forum Infect. Dis. 2019;6:ofz194. doi: 10.1093/ofid/ofz194. - DOI - PMC - PubMed
-
- Landewé R.B.M., Günther K.P., Lukas C., Braun J., Combe B., Conaghan P., Dreinhöfer K., Fritschy D., Getty J., van der Heide H.J., et al. EULAR/EFORT recommendations for the diagnosis and initial management of patients with acute or recent onset swelling of the knee. Ann. Rheum. Dis. 2009;69:12–19. doi: 10.1136/ard.2008.104406. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous